251 related articles for article (PubMed ID: 17517063)
101. Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents.
Vercauteren K; Van Den Eede N; Mesalam AA; Belouzard S; Catanese MT; Bankwitz D; Wong-Staal F; Cortese R; Dubuisson J; Rice CM; Pietschmann T; Leroux-Roels G; Nicosia A; Meuleman P
Hepatology; 2014 Nov; 60(5):1508-18. PubMed ID: 24797654
[TBL] [Abstract][Full Text] [Related]
102. Scavenger receptor class B type I is more conducive for genotype 1b hepatitis C virus internalization than low-density lipoprotein receptor.
Cao X; Kang Q; Deng J; Xiao J; Zhang Y; Ma P; Yang X; Lv L
Acta Virol; 2021; 65(3):279-287. PubMed ID: 34565156
[TBL] [Abstract][Full Text] [Related]
103. Lipoprotein lipase (EC 3.1.1.34) targeting of lipoproteins to receptors.
Beisiegel U; Heeren J
Proc Nutr Soc; 1997 Jul; 56(2):731-7. PubMed ID: 9264123
[TBL] [Abstract][Full Text] [Related]
104. Interplay between hepatitis C virus and lipid metabolism during virus entry and assembly.
Lavie M; Dubuisson J
Biochimie; 2017 Oct; 141():62-69. PubMed ID: 28630011
[TBL] [Abstract][Full Text] [Related]
105. The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus.
Dreux M; Boson B; Ricard-Blum S; Molle J; Lavillette D; Bartosch B; Pécheur EI; Cosset FL
J Biol Chem; 2007 Nov; 282(44):32357-69. PubMed ID: 17761674
[TBL] [Abstract][Full Text] [Related]
106. [Roles of lipoprotein and apolipoprotein in HCV infection].
Fukuhara T; Matsuura Y
Uirusu; 2015; 65(2):269-276. PubMed ID: 27760926
[TBL] [Abstract][Full Text] [Related]
107. Human serum amyloid A protein inhibits hepatitis C virus entry into cells.
Cai Z; Cai L; Jiang J; Chang KS; van der Westhuyzen DR; Luo G
J Virol; 2007 Jun; 81(11):6128-33. PubMed ID: 17329325
[TBL] [Abstract][Full Text] [Related]
108. Hepatitis C virus relies on lipoproteins for its life cycle.
Grassi G; Di Caprio G; Fimia GM; Ippolito G; Tripodi M; Alonzi T
World J Gastroenterol; 2016 Feb; 22(6):1953-65. PubMed ID: 26877603
[TBL] [Abstract][Full Text] [Related]
109. The Role of ApoE in HCV Infection and Comorbidity.
Gong Y; Cun W
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027190
[TBL] [Abstract][Full Text] [Related]
110. Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease.
Felmlee DJ; Hafirassou ML; Lefevre M; Baumert TF; Schuster C
Viruses; 2013 May; 5(5):1292-324. PubMed ID: 23698400
[TBL] [Abstract][Full Text] [Related]
111. Primary hepatocytes as targets for hepatitis C virus replication.
Farquhar MJ; McKeating JA
J Viral Hepat; 2008 Dec; 15(12):849-54. PubMed ID: 19087224
[TBL] [Abstract][Full Text] [Related]
112. Extracellular Interactions between Hepatitis C Virus and Secreted Apolipoprotein E.
Li Z; Li Y; Bi Y; Zhang H; Yao Y; Li Q; Cun W; Dong S
J Virol; 2017 Aug; 91(15):. PubMed ID: 28539442
[TBL] [Abstract][Full Text] [Related]
113. Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat).
Lookene A; Skottova N; Olivecrona G
Eur J Biochem; 1994 Jun; 222(2):395-403. PubMed ID: 8020477
[TBL] [Abstract][Full Text] [Related]
114. Several Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released Viruses.
Hueging K; Weller R; Doepke M; Vieyres G; Todt D; Wölk B; Vondran FW; Geffers R; Lauber C; Kaderali L; Penin F; Pietschmann T
PLoS One; 2015; 10(7):e0134529. PubMed ID: 26226615
[TBL] [Abstract][Full Text] [Related]
115. Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor.
Owen DM; Huang H; Ye J; Gale M
Virology; 2009 Nov; 394(1):99-108. PubMed ID: 19751943
[TBL] [Abstract][Full Text] [Related]
116. Apolipoprotein E and lipoprotein lipase increase triglyceride-rich particle binding but decrease particle penetration in arterial wall.
Mullick AE; Deckelbaum RJ; Goldberg IJ; Al-Haideri M; Rutledge JC
Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):2080-5. PubMed ID: 12482838
[TBL] [Abstract][Full Text] [Related]
117. Building a mechanistic mathematical model of hepatitis C virus entry.
Kalemera M; Mincheva D; Grove J; Illingworth CJR
PLoS Comput Biol; 2019 Mar; 15(3):e1006905. PubMed ID: 30883541
[TBL] [Abstract][Full Text] [Related]
118. Apolipoprotein c1 association with hepatitis C virus.
Meunier JC; Russell RS; Engle RE; Faulk KN; Purcell RH; Emerson SU
J Virol; 2008 Oct; 82(19):9647-56. PubMed ID: 18667498
[TBL] [Abstract][Full Text] [Related]
119. Fetal bovine serum inhibits hepatitis C virus attachment to host cells.
Qin ZL; Ju HP; Liu Y; Gao TT; Wang WB; Aurelian L; Zhao P; Qi ZT
J Virol Methods; 2013 Nov; 193(2):261-9. PubMed ID: 23845899
[TBL] [Abstract][Full Text] [Related]
120. Synthetic anti-lipopolysaccharide peptides and hepatitis C virus infection.
Habersetzer F; Leboeuf C; Doffoël M; Zeisel MB; Baumert TF
Expert Opin Investig Drugs; 2013 Jul; 22(7):853-62. PubMed ID: 23634817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
